| HIV latency reversal agents: A potential path for functional cure? JR Lopes, DE Chiba, JL Dos Santos European Journal of Medicinal Chemistry 213, 113213, 2021 | 15 | 2021 |
| Resveratrol and curcumin for Chagas disease treatment—a systematic review CHL Imperador, CB Scarim, PL Bosquesi, JR Lopes, A Cardinalli Neto, ... Pharmaceuticals 15 (5), 609, 2022 | 10 | 2022 |
| The state of the art of fetal hemoglobin-inducing agents AR Pavan, JR Lopes, JL Dos Santos Expert Opinion on Drug Discovery 17 (11), 1279-1293, 2022 | 8 | 2022 |
| Phthalimide as a versatile pharmacophore scaffold: Unlocking its diverse biological activities GFS Fernandes, JR Lopes, JL Dos Santos, CB Scarim Drug Development Research 84 (7), 1346-1375, 2023 | 7 | 2023 |
| The application of prodrugs as a tool to enhance the properties of nucleoside reverse transcriptase inhibitors LR Fernandes, JR Lopes, AF Bonjorno, JLB Prates, CB Scarim, ... Viruses 15 (11), 2234, 2023 | 6 | 2023 |
| Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections B Terroni, JR Lopes, CM Chin, JL dos Santos Coronaviruses, 2021 | 4 | 2021 |
| Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruzi JLB Prates, JR Lopes, CM Chin, EI Ferreira, JL Dos Santos, CB Scarim Current Medicinal Chemistry 31 (16), 2285-2308, 2024 | 3 | 2024 |
| Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease JL Dos Santos, AR Pavan, JR Lopes, CH Imperador, C ManChin Frontiers in Medicine, 2705, 2022 | 2* | 2022 |
| Design and synthesis of hybrid compounds as epigenetic modifiers JR Lopes, IM Prokopczyk, M Gerlack, C Man Chin, JLD Santos Pharmaceuticals 14 (12), 1308, 2021 | 2 | 2021 |
| Advances in drug discovery of flavivirus NS2B-NS3pro serine protease inhibitors for the treatment of Dengue, Zika, and West Nile viruses EE João, JR Lopes, BFR Guedes, PR da Silva Sanches, CM Chin, ... Bioorganic Chemistry, 107914, 2024 | 1 | 2024 |
| Desenvolvimento de fármacos para tratamento da COVID-19 JR Lopes, CHL Imperador, CM Chin, JL dos Santos ULAKES JOURNAL OF MEDICINE 1, 2020 | 1 | 2020 |
| Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment AL Rodriguez Gini, EE João, JR Lopes, PST Da Cunha, ... Current Drug Targets 26 (2), 88-108, 2025 | | 2025 |
| Planejamento, síntese e avaliação farmacológica de derivados de ácidos borônicos como inibidores da protease principal de SARS-COV-2 JR Lopes Universidade Estadual Paulista (Unesp), 2024 | | 2024 |
| BacPROTAC approach for tuberculosis drug discovery AF Bonjorno, AR Pavan, JR Lopes, JLB Prates, MM de Souza, CB Scarim, ... Annual Reports in Medicinal Chemistry 63, 93-112, 2024 | | 2024 |
| Epigenetic modulations induced by natural products AR Pavan, AF Bonjorno, DE Chiba, JR Lopes, L da Rocha Fernandes, ... Natural Molecules in Neuroprotection and Neurotoxicity, 199-227, 2024 | | 2024 |
| Planejamento, síntese e caracterização de derivados benzofuroxanos acoplados a carbonilas α, β insaturadas como inibidores de cruzaína PST da Cunha, JR Lopes, JL dos Santos, CB Scarim XI Congresso Farmacêutico e VII Jornada de Engenharia de Bioprocessos e …, 2023 | | 2023 |
| Novos derivados de hidrazonas como inibidores de cruzaína para o tratamento da doença de Chagas ALR Gini, LA Diniz, PST da Cunha, JR Lopes, IM Prokopczyk, ... XI Congresso Farmacêutico e VII Jornada de Engenharia de Bioprocessos e …, 2023 | | 2023 |
| Molecular Modeling and Synthesis of New HIV Latency-Reversing Agents Targeting the Lymphatic System BM Rodrigues, JR Lopes, AF Bonjorno, JL dos Santos Medical Sciences Forum 14 (1), 3, 2022 | | 2022 |
| Synthesis of boronic acid derivatives designed as SARS-CoV-2 MPro inhibitors J Lopes, JL Santos, MO Godoy, RVC Guido Anais eletrônicos, 2022 | | 2022 |
| Design and synthesis of new hybrid latency reversal agents for HIV treatment JR Lopes, I Prokopczyk, JL Dos Santos MDPI, 2020 | | 2020 |
